EquityZen Review

EquityZen Review 2026: Pre-IPO Investing Gets Institutional Backing After Morgan Stanley Acquisition

Last verified: 2026-04-12 | Overall rating: 3.8/5

The 30-Second Verdict

EquityZen is a regulated secondary marketplace for buying and selling shares in late-stage private companies before they go public. Acquired by Morgan Stanley in January 2026, the platform cut fees from 5% to 2.5% and now serves 800,000+ users. The $5,000 minimum is accessible for the pre-IPO space, and SEC/FINRA/SIPC oversight provides meaningful investor protections. The trade-off: accredited investors only, lock-up periods after IPO, and the inherent uncertainty of betting on private company exits.

What Is EquityZen and How Does It Work?

EquityZen operates as an SEC-registered broker-dealer and FINRA member that facilitates secondary market transactions in pre-IPO company shares. Investors buy shares from existing shareholders (employees, early investors) through Rule 506(b) Regulation D private placements. The platform also offers curated funds with diversified exposure across multiple private companies. EquityZen does not buy shares from companies directly -- it matches buyers and sellers on its marketplace.

Who Is EquityZen Best For?

EquityZen is best for accredited investors who want exposure to late-stage private companies before IPO, have a medium-to-long-term holding horizon, and are comfortable with illiquidity. The $5,000 minimum makes it more accessible than traditional secondary market brokers. If you want daily liquidity, stick to public markets. If you are not accredited, this platform is off limits. For broader private market access (not just pre-IPO), consider Forge Global.

Fees

• Transaction fee: 2.5% on buys and sells (reduced from 5% in February 2026)
• No account setup fee
• No annual maintenance fee

On a $5,000 investment: $125 transaction fee on purchase + $125 on eventual sale = $250 total round-trip cost (5% of principal). The fee reduction post-Morgan Stanley acquisition is significant but still adds up for active traders.

Minimum Investment

$5,000 for individual share purchases. Curated funds require $20,000 minimum.

Accreditation Requirements

Accredited investor status required. The platform has 430,000+ accredited investors among its 800,000+ total users.

Liquidity -- How Do You Get Your Money Out?

EquityZen's secondary marketplace provides some liquidity, but selling is not guaranteed. Sales require company approval, and companies have right of first refusal. After IPO, lock-up periods prevent immediate share sales. Payment processing on sales can be slow, and customer service responsiveness issues have been reported. Not all companies have active buyer interest.

Historical Returns

EquityZen reports 15-25% net IRR for curated funds as of January 2026. Returns depend heavily on company exit timing and are not independently verified. Individual investments can range from total loss to significant multiples depending on the company's trajectory.

Any returns referenced are self-reported and not independently verified.

Regulatory and Legal Structure

EquityZen is registered with the SEC, is a FINRA member, and carries SIPC protection. Offerings are structured as Rule 506(b) Regulation D private placements. The January 2026 acquisition by Morgan Stanley provides additional institutional backing. This is one of the most heavily regulated platforms in the pre-IPO space.

Pros

• SEC, FINRA, and SIPC regulated with institutional backing from Morgan Stanley
• Competitive 2.5% transaction fee (reduced from 5% in February 2026)
• Low $5,000 minimum investment for pre-IPO shares
• Active secondary marketplace with 800,000+ users
• Curated selection of well-known late-stage private companies
• Flexible account types including self-directed IRAs and trusts

Cons

• 2.5% fees on both buys and sells create a 5% round-trip cost
• Accredited investor requirement limits access
• Lock-up periods after IPO prevent immediate sale of shares
• Company approval required for sales with right of first refusal barriers
• Limited liquidity -- not all companies have active buyers on the marketplace
• Slower payment processing on sales and reported customer service responsiveness issues

The Bottom Line

The Morgan Stanley acquisition transformed EquityZen from a niche pre-IPO marketplace into an institutionally-backed platform with meaningful fee reductions and deeper liquidity. The 2.5% transaction fee is competitive for the space, and the SEC/FINRA/SIPC regulatory framework provides protections that many alternative investment platforms lack.

The core risk has not changed: pre-IPO investing is speculative, illiquid, and dependent on exit timing. But for accredited investors who understand those risks and want curated access to late-stage private companies, EquityZen is now one of the strongest options available. The $5,000 minimum keeps it accessible, and the institutional backing reduces platform-level risk.

ModernAlts may receive compensation if you open an account with platforms reviewed on this site. This does not influence our editorial ratings or analysis. Alternative investments involve risk, including possible loss of principal. Past performance is not indicative of future results. Nothing on this site constitutes investment, legal, or tax advice.